Teleflex Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,696
1,827
1,810
1,868
2,146
2,448
Cost of Goods Sold (COGS) incl. D&A
856
898
855
859
971
1,053
Gross Income
840
929
955
1,009
1,176
1,396
SG&A Expense
551
634
624
623
776
930
EBIT
289
-
-
387
400
466
Unusual Expense
57
10
25
86
34
148
Non Operating Income/Expense
-
-
1
-
-
4
Interest Expense
57
65
61
55
83
103
Pretax Income
176
220
245
246
285
220
Income Tax
24
29
8
8
130
23
Consolidated Net Income
152
191
237
238
155
196
Net Income
151
190
236
237
155
196
Net Income After Extraordinaries
152
193
227
237
158
192
Net Income Available to Common
151
188
245
237
153
201
EPS (Basic)
3.45
4.04
5.10
4.98
3.27
4.29
Basic Shares Outstanding
41
41
42
43
45
46
EPS (Diluted)
3.45
4.04
5.10
4.98
3.27
4.29
Diluted Shares Outstanding
44
46
48
48
47
47
EBITDA
382
406
439
504
555
676
Non-Operating Interest Income
-
1
1
1
1
1
Minority Interest Expense
-
1
1
1
-
-

About Teleflex

View Profile
Address
550 East Swedesford Road
Wayne Pennsylvania 19087
United States
Employees -
Website http://www.teleflex.com
Updated 07/08/2019
Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Vascular North America, Interventional North America, Anesthesia North America, Surgical North America, Europe, the Middle East and Africa (EMEA), Asia and Original Equipment Manufacturer and Development Services (OEM).